Objectives GIVEN THE ONGOING EPIDEMIC AND PROVEN LIFE-SAVING IMPACT OF NALOXONE, EMERGENT TOOK ACTION TO HELP BROADEN ACCESS. In March 2023, the U.S. Food and Drug Administration approved NARCAN® ...
(NYSE: EBS) remains committed to supporting widespread opioid emergency preparedness by expanding access to NARCAN ® Nasal Spray and educating the public on how to respond to an opioid overdose.
“We continue to run into it through EMS calls and hospitals.” Similar programs are starting all across the country to combat the nationwide crisis. JCAS Paramedic Field Supervisor Andreas Wilz said ...
Ongoing support of the ‘White House Challenge to Save Lives from Overdose’ through workplace and public safety measures One-year mark of Ready to Rescue public awareness campaign to ...
If these signs are present, call 911 and administer naloxone. Naloxone, an opioid antagonist, rapidly displaces the opioids, such as tramadol and hydrocodone, that are bound to the opioid receptors.